|
1
|
Nasim F, Sabath BF and Eapen GA: Lung
cancer. Med Clin North Am. 103:463–473. 2019.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Oliver AL: Lung cancer: Epidemiology and
screening. Surg Clin North Am. 102:335–344. 2022.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Spitz MR, Wei Q, Dong Q, Amos CI and Wu X:
Genetic susceptibility to lung cancer: The role of DNA damage and
repair. Cancer Epidemiol Biomarkers Prev. 12:689–698.
2003.PubMed/NCBI
|
|
4
|
Rodriguez-Canales J, Parra-Cuentas E and
Wistuba II: Diagnosis and molecular classification of lung cancer.
Cancer Treat Res. 170:25–46. 2016.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Pande M, Spitz MR, Wu X, Gorlov IP, Chen
WV and Amos CI: Novel genetic variants in the chromosome 5p15.33
region associate with lung cancer risk. Carcinogenesis.
32:1493–1499. 2011.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Yamamoto K, Okamoto A, Isonishi S, Ochiai
K and Ohtake Y: A novel gene, CRR9, which was up-regulated in
CDDP-resistant ovarian tumor cell line, was associated with
apoptosis. Biochem Biophys Res Commun. 280:1148–1154.
2001.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Petersen GM, Amundadottir L, Fuchs CS,
Kraft P, Stolzenberg-Solomon RZ, Jacobs KB, Arslan AA,
Bueno-de-Mesquita HB, Gallinger S, Gross M, et al: A genome-wide
association study identifies pancreatic cancer susceptibility loci
on chromosomes 13q22.1, 1q32.1 and 5p15.33. Nat Genet. 42:224–228.
2010.PubMed/NCBI View
Article : Google Scholar
|
|
8
|
Tian J, Wang Y, Dong Y, Chang J, Wu Y,
Chang S and Che G: Cumulative evidence for relationships between
multiple variants in the TERT and CLPTM1L region and risk of cancer
and non-cancer disease. Front Oncol. 12(946039)2022.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Derrien AC, Houy A, Ganier O, Dingli F,
Ningarhari M, Mobuchon L, Espejo Díaz MI, Loew D, Cassoux N,
Cussenot O, et al: Functional characterization of 5p15.33 risk
locus in uveal melanoma reveals rs452384 as a functional variant
and NKX2.4 as an allele-specific interactor. Am J Hum Genet.
109:2196–2209. 2022.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Petkov S and Chiodi F: Distinct
transcriptomic profiles of naïve CD4+ T cells distinguish HIV-1
infected patients initiating antiretroviral therapy at acute or
chronic phase of infection. Genomics. 113:3487–3500. 2021.
|
|
11
|
Aktas G, Sit M, Karagoz I, Erkus E, Ozer
B, Kocak MZ, Yaman S, Keyif F, Altinordu R, Erkol H and Savli H:
Could red cell distribution width be a marker of thyroid cancer? J
Coll Physicians Surg Pak. 27:556–558. 2017.PubMed/NCBI
|
|
12
|
Speedy HE, Di Bernardo MC, Sava GP, Dyer
MJ, Holroyd A, Wang Y, Sunter NJ, Mansouri L, Juliusson G, Smedby
KE, et al: A genome-wide association study identifies multiple
susceptibility loci for chronic lymphocytic leukemia. Nat Genet.
46:56–60. 2014.PubMed/NCBI View
Article : Google Scholar
|
|
13
|
James MA, Wen W, Wang Y, Byers LA, Heymach
JV, Coombes KR, Girard L, Minna J and You M: Functional
characterization of CLPTM1L as a lung cancer risk candidate gene in
the 5p15.33 locus. PLoS One. 7(e36116)2012.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Li C, Yin Z, Wu W, Li X and Zhou B:
Genetic variants in TERT-CLPTM1L genetic region associated with
several types of cancer: A meta-analysis. Gene. 526:390–399.
2013.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Kachuri L, Amos CI, McKay JD, Johansson M,
Vineis P, Bueno-de-Mesquita HB, Boutron-Ruault MC, Johansson M,
Quirós JR, Sieri S, et al: Fine mapping of chromosome 5p15.33 based
on a targeted deep sequencing and high density genotyping
identifies novel lung cancer susceptibility loci. Carcinogenesis.
37:96–105. 2016.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Liang Y, Thakur A, Gao L, Wang T, Zhang S,
Ren H, Meng J, Geng T, Jin T and Chen M: Correlation of CLPTM1L
polymorphisms with lung cancer susceptibility and response to
cisplatin-based chemotherapy in a Chinese Han population. Tumour
Biol. 35:12075–12082. 2014.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Pintarelli G, Cotroneo CE, Noci S, Dugo M,
Galvan A, Delli Carpini S, Citterio L, Manunta P, Incarbone M, Tosi
D, et al: Genetic susceptibility variants for lung cancer:
Replication study and assessment as expression quantitative trait
loci. Sci Rep. 7(42185)2017.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Xun X, Wang H, Yang H, Wang H, Wang B,
Kang L, Jin T and Chen C: CLPTM1L genetic polymorphisms and
interaction with smoking and alcohol drinking in lung cancer risk:
A case-control study in the Han population from northwest China.
Medicine (Baltimore). 93(e289)2014.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Yang YC, Fu WP, Zhang J, Zhong L, Cai SX
and Sun C: rs401681 and rs402710 confer lung cancer susceptibility
by regulating TERT expression instead of CLPTM1L in east Asian
populations. Carcinogenesis. 39:1216–1221. 2018.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Zhao MM, Zhang Y, Shen L, Ren YW, Li XL,
Yin ZH and Zhou BS: Genetic variations in TERT-CLPTM1L genes and
risk of lung cancer in a Chinese population. Asian Pac J Cancer
Prev. 15:2809–2813. 2014.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Cook DA and Reed DA: Appraising the
quality of medical education research methods: The medical
education research study quality instrument and the
Newcastle-Ottawa scale-education. Acad Med. 90:1067–1076.
2015.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Fan S, Meng J, Zhang L, Zhang X and Liang
C: CAV1 polymorphisms rs1049334, rs1049337, rs7804372 might be the
potential risk in tumorigenicity of urinary cancer: A systematic
review and meta-analysis. Pathol Res Pract. 215:151–158.
2019.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Meng J, Fan X, Zhang M, Hao Z and Liang C:
Do polymorphisms in protein kinase catalytic subunit alpha-1 gene
associated with cancer susceptibility? a meta-analysis and
systematic review. BMC Med Genet. 19(189)2018.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Meng J, Wang S, Shen X, Bai Z, Niu Q, Ma
D, Xu Y and Liang C: Polymorphism of MMP-9 gene is not associated
with the risk of urinary cancers: Evidence from an updated
meta-analysis. Pathol Res Pract. 214:1966–1973. 2018.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Tang Z, Li C, Kang B, Gao G, Li C and
Zhang Z: GEPIA: A web server for cancer and normal gene expression
profiling and interactive analyses. Nucleic Acids Res. 45:W98–W102.
2017.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Amos CI, Wu X, Broderick P, Gorlov IP, Gu
J, Eisen T, Dong Q, Zhang Q, Gu X, Vijayakrishnan J, et al:
Genome-wide association scan of tag SNPs identifies a
susceptibility locus for lung cancer at 15q25.1. Nat Genet.
40:616–622. 2008.PubMed/NCBI View
Article : Google Scholar
|
|
27
|
Bae EY, Lee SY, Kang BK, Lee EJ, Choi YY,
Kang HG, Choi JE, Jeon HS, Lee WK, Kam S, et al: Replication of
results of genome-wide association studies on lung cancer
susceptibility loci in a Korean population. Respirology.
17:699–706. 2012.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Chen XF, Cai S, Chen QG, Ni ZH, Tang JH,
Xu DW and Wang XB: Multiple variants of TERT and CLPTM1L constitute
risk factors for lung adenocarcinoma. Genet Mol Res. 11:370–378.
2012.PubMed/NCBI View Article : Google Scholar
|
|
29
|
de Mello RA, Ferreira M, Soares-Pires F,
Costa S, Cunha J, Oliveira P, Hespanhol V and Reis RM: The impact
of polymorphic variations in the 5p15, 6p12, 6p21 and 15q25 loci on
the risk and prognosis of portuguese patients with non-small cell
lung cancer. PLoS One. 8(e72373)2013.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Hung RJ, McKay JD, Gaborieau V, Boffetta
P, Hashibe M, Zaridze D, Mukeria A, Szeszenia-Dabrowska N,
Lissowska J, Rudnai P, et al: A susceptibility locus for lung
cancer maps to nicotinic acetylcholine receptor subunit genes on
15q25. Nature. 452:633–637. 2008.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Jiang M, Wu H and Qin C: Genetic variant
rs401681 at 5p15.33 modifies susceptibility to lung cancer but not
esophageal squamous cell carcinoma. PLoS One.
8(e84277)2013.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Jin T, Li B, He N, Zhang Y, Xia R, Kang L,
Ding Y and Yuan D: CLPTM1L polymorphism as a protective factor for
lung cancer: A case-control study in southern Chinese population.
Tumour Biol. 37:10533–10538. 2016.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Ke J, Zhong R, Zhang T, Liu L, Rui R, Shen
N, Sun Y, Liu L, Cheng L and Miao XP: Replication study in Chinese
population and meta-analysis supports association of the 5p15.33
locus with lung cancer. PLoS One. 8(e62485)2013.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Liu SG, Ma L, Cen QH, Huang JS, Zhang JX
and Zhang JJ: Association of genetic polymorphisms in TERT-CLPTM1L
with lung cancer in a Chinese population. Genet Mol Res.
14:4469–4476. 2015.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Myneni AA, Chang SC, Niu R, Liu L,
Ochs-Balcom HM, Li Y, Zhang C, Zhao B, Shi J, Han X, et al: Genetic
polymorphisms of TERT and CLPTM1L and risk of lung cancer-a
case-control study in a Chinese population. Lung Cancer.
80:131–137. 2013.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Sun Y, Zhang YJ and Kong XM: No
association of XRCC1 and CLPTM1L polymorphisms with non-small cell
lung cancer in a non-smoking Han Chinese population. Asian Pac J
Cancer Prev. 14:5171–5174. 2013.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Wang H, Zhao Y, Ma J, Zhang G, Mu Y, Qi G,
Fang Z, Wang L, Fan Q and Ma Z: The genetic variant rs401681C/T is
associated with the risk of non-small cell lung cancer in a Chinese
mainland population. Genet Mol Res. 12:67–73. 2013.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Wang Y, Broderick P, Webb E, Wu X,
Vijayakrishnan J, Matakidou A, Qureshi M, Dong Q, Gu X, Chen WV, et
al: Common 5p15.33 and 6p21.33 variants influence lung cancer risk.
Nat Genet. 40:1407–1409. 2008.PubMed/NCBI View
Article : Google Scholar
|
|
39
|
Xiao X and He W: Genetic polymorphisms in
the TERT-CLPTM1L region and lung cancer susceptibility in Chinese
males. Oncol Lett. 14:1588–1594. 2017.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Yoon KA, Park JH, Han J, Park S, Lee GK,
Han JY, Zo JI, Kim J, Lee JE, Takahashi A, et al: A genome-wide
association study reveals susceptibility variants for non-small
cell lung cancer in the Korean population. Hum Mol Genet.
19:4948–4954. 2010.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Zhang Y, Zhao M, Shen L, Ren Y, Su L, Li
X, Yin Z and Zhou B: Genetic polymorphisms of TERT and CLPTM1L and
risk of lung cancer: A case-control study in northeast Chinese male
population. Med Oncol. 31(18)2014.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Zienolddiny S, Skaug V, Landvik NE, Ryberg
D, Phillips DH, Houlston R and Haugen A: The TERT-CLPTM1L lung
cancer susceptibility variant associates with higher DNA adduct
formation in the lung. Carcinogenesis. 30:1368–1371.
2009.PubMed/NCBI View Article : Google Scholar
|
|
43
|
XZ L: The CLPTM1L variant rs401681 is
associated with lung cancer risk. Huazhong University of Science
and Technology, 2013. https://xueshu.baidu.com/usercenter/paper/show?paperid=a716ba54558bed957b7463d7e5bf6c75&site=xueshu_se.
|
|
44
|
Liu C, Wang Y, Huang H, Wang C and Zhang
H, Kong Y and Zhang H: Association between CLPTM1L-TERT rs401681
polymorphism and pancreatic cancer risk among Chinese Han
population. Tumor Biol. 35:5453–5457. 2014.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Vaiciulis P, Liutkeviciene R, Liutkevicius
V, Vilkeviciute A, Gedvilaite G and Uloza V: Association of
relative leucocyte telomere length and gene single nucleotide
polymorphisms (TERT, TRF1, TNKS2) in laryngeal squamous cell
carcinoma. Cancer Genomics Proteomics. 17:431–439. 2020.PubMed/NCBI View Article : Google Scholar
|
